Truscreen Group Limited, together with its subsidiaries, engages in the development, manufacture, and sale of cancer detection devices and systems in Mexico, China, Russia, Vietnam, Zimbabwe, Eastern Europe, the Middle East/North Africa, and internationally. The company offers the TruScreen cervical cancer screening device, a medical device for identifying and detecting the presence of precancerous and cancerous tissue on the cervix in real time. The company was formerly known as TruScreen Limited and changed its name to Truscreen Group Limited in August 2020. Truscreen Group Limited was incorporated in 2013 and is headquartered in Auckland, New Zealand.
| Market Capitalization | $9.9994 million |
| P/E Ratio | 0 |
| P/E Growth Ratio | |
| Book Value | 0.006 |
| Dividend Per Share | 0 |
| Earnings Per Share | -0.01 |
| EBITDA | -1,886.801 |
| Profit Margin | -1.1554 |
| Operating Margin TTM | -1.1162 |
| Return on Assets TTM | -0.3692 |
| Return on Equity TTM | -0.8091 |
| Revenue TTM | 2,078.747 |
All numbers are in thousands
| Date | Total Revenue | Cost of Revenue | Gross Profit | Total Operating Expenses |
|---|---|---|---|---|
| 2015-12-31 | 472.1 | 252.94 | 219.16 | |
| 2016-12-31 | 585.388 | 472.802 | 112.586 | |
| 2017-12-31 | 804.062 | 807.95 | -3.888 | |
| 2018-12-31 | 1,862.949 | 1,334.837 | 528.112 | |
| 2019-12-31 | 1,288.242 | 772.02 | 516.222 | 4,635.062 |
| 2020-12-31 | 1,132.641 | 732.603 | 400.038 | 4,562.566 |
| 2021-12-31 | 1,678.465 | 1,155.725 | 522.74 | 9,389.326 |
| 2022-12-31 | 1,662.619 | 1,202.628 | 459.991 | 3,401.847 |
All numbers are in thousands
| Date | Cash | Total Assets | Total Liabilities | Short Term Debt | Long Term Debt | Common Stock |
|---|---|---|---|---|---|---|
| 2015-12-31 | 2,304.7 | 14,575.85 | 429.43 | 17,840.46 | ||
| 2016-12-31 | 3,671.571 | 15,041.48 | 717.192 | 21,800.585 | ||
| 2017-12-31 | 1,212.454 | 12,166.849 | 550.967 | 23,433.996 | ||
| 2018-12-31 | 1,737.775 | 12,545.765 | 1,224.956 | 626.5 | 26,421.168 | |
| 2019-12-31 | 1,024.153 | 8,074.01 | 832.943 | 410.28 | 27,492.05 | |
| 2020-12-31 | 5,255.074 | 12,004.691 | 695.5 | 34,550.048 | ||
| 2021-12-31 | 2,797.004 | 4,386.944 | 991.893 | 34,550.048 | ||
| 2022-12-31 | 2,160.468 | 3,470.183 | 928.159 | 36,097.125 |
All numbers are in thousands
| Date | Net Income | Total Cash | Change in Cash | Begin period cash | End period cash | Dividends |
|---|---|---|---|---|---|---|
| 2015-12-31 | -662.1 | 1,770.41 | 2,304.698 | |||
| 2016-12-31 | -3,540.61 | -2,575.584 | 1,366.873 | 2,304.698 | 3,671.571 | |
| 2017-12-31 | -4,168.792 | -3,729.191 | -2,459.117 | 3,671.571 | 1,212.454 | |
| 2018-12-31 | -3,380.454 | -2,678.321 | 525.321 | 1,212.454 | 1,737.775 | |
| 2019-12-31 | -5,196.721 | -1,634.499 | -713.622 | 1,737.775 | 1,024.153 | |
| 2020-12-31 | -3,490.01 | -2,189.331 | 4,230.921 | 1,024.153 | 5,255.074 | |
| 2021-12-31 | -7,892.672 | -2,531.697 | -2,458.07 | 5,255.074 | 2,797.004 | |
| 2022-12-31 | -2,401.84 | -636.536 | 2,797.004 | 2,160.468 |